Akero Therapeutics, Inc. logo

Akero Therapeutics, Inc. (AKRO)

Delisted
9 Dec 2025
NASDAQ (NGS) NASDAQ (NGS)
$
54. 65
0
0%
$
4.47B Market Cap
- P/E Ratio
- Div Yield
11.61M Volume
-2.84 Eps
$ 54.65
Previous Close
Investors:
Day Range
54.52 54.65
Year Range
21.34 58.4
Want to track AKRO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Akero Therapeutics, Inc. logo
AKRO Akero Therapeutics, Inc.
6 Nov 2025
-
-
Akero Therapeutics, Inc. logo
AKRO Akero Therapeutics, Inc.
8 Aug 2025
-
-
Akero Therapeutics, Inc. logo
AKRO Akero Therapeutics, Inc.
8 May 2025
-
-
Akero Therapeutics, Inc. logo
AKRO Akero Therapeutics, Inc.
26 Feb 2025
-
-
Akero Therapeutics, Inc. logo
AKRO Akero Therapeutics, Inc.
11 Nov 2024
-
-
Akero Therapeutics, Inc. logo
AKRO Akero Therapeutics, Inc.
9 Aug 2024
-
-
Akero Therapeutics, Inc. logo
AKRO Akero Therapeutics, Inc.
13 May 2024
-
-
Akero Therapeutics, Inc. logo
AKRO Akero Therapeutics, Inc.
29 Feb 2024
-
-
Akero Therapeutics, Inc. logo
AKRO Akero Therapeutics, Inc.
2 Nov 2023
-
-